泪道设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球泪道设备市场价值为 1.602 亿美元，预计到 2034 年将以 4.2% 的复合年增长率增长，达到 2.415 亿美元，这得益于全球眼部健康状况的日益恶化以及医疗技术的持续进步。随着人们眼部护理意识的提高和医疗基础设施的加强，尤其是在新兴经济体，对现代泪道解决方案的需求正在增长。与环境因素、数位萤幕暴露和人口老化相关的干眼症发病率上升是导致这一趋势的关键因素。随着人们的注意力转向高效和微创治疗，智慧诊断工具和创新手术方法的应用正在增加。旨在促进眼科研究和创新的政府支持政策也发挥着重要作用。

製造商优先考虑以使用者为中心的产品设计，强调舒适性和生物相容性，以顺应日益增长的个人化照护需求。透过客製化泪道装置以满足个别患者需求，企业正在提升治疗效果，同时提高装置的耐受性和患者依从性。这种个人化转变也包括开发不易引发免疫反应、能与眼部组织更自然结合的材料。此外，医疗专业人士、产业参与者和研究机构之间的合作正在加速开发更有效的泪道治疗方案和装置。这些合作促进创新，将临床洞察与先进的工程技术和数据驱动的设计相结合，从而为干眼症和鼻泪管阻塞等疾病提供下一代解决方案。

预计支架市场将以4.6%的复合年增长率显着成长，到2034年将达到6,790万美元。支架在治疗老年和儿童泪道系统疾病的应用日益广泛，推动了该市场的发展。其卓越的临床疗效、简单的设计和使用者友善的置入技术，使其成为眼科专家的首选。生物可吸收和自固定支架设计的不断改进，有助于减少併发症，改善患者体验，并最大限度地减少后续手术的需求。

2024年，干眼症治疗领域占40.1%的市场份额，并且由于大众和临床对干眼症的认知度不断提高，该领域市场份额将继续增长。干眼症与慢性疾病之间的联繫，使得针对性治疗方法的紧迫性日益凸显。先进的泪液管理和诊断技术提高了治疗决策的准确性，从而促进了干眼症治疗的更广泛应用。人们对早期发现和介入的认识不断提高，也促进了该领域的发展势头。

美国泪道治疗设备市场在2024年达到5,350万美元，未来预计将迎来大幅成长，这主要得益于人口老化，因为老化更容易导致泪道功能障碍。老年人罹患慢性疾病（例如关节炎、糖尿病和自体免疫疾病）的风险更高，而这些疾病中的许多都会导致泪管和眼表併发症，因此对有效且微创的泪道治疗的需求持续增长。对创新治疗模式的日益关注、优惠的报销政策以及手术技术的持续改进，正在支持该地区市场的成长。

活跃于市场的主要参与者包括Medennium、FCI、B. Braun、Rumex、Bess Medical、Kaneka Medical Products、Surtex Instruments、JEDMED、OASIS、GWSG、Aurolab、Innovia Medical、Braintree、BVI和Walsh Medical Devices。为了巩固市场地位，各公司纷纷投资研发生物相容性强、有效率且病患友善的医疗器材。与医疗机构的策略合作有助于提升产品知名度和临床认可度。拓展全球分销网络并在新地区寻求监管批准是常见的策略。各公司利用数位行销和临床培训计画来提升从业人员的参与度和产品利用率。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 眼部疾病盛行率不断上升
    • 泪道治疗程序的简易性
    • 泪道装置的技术进步
  • 产业陷阱与挑战
    • 副作用风险高
• 成长潜力分析
• 监管格局
• 川普政府关税
  • 对贸易的影响
    • 贸易量中断
    • 各国应对措施
  • 对产业的影响
    • 供应方影响（製造成本）
      • 主要材料价格波动
      • 供应链重组
      • 生产成本影响
    • 需求面影响（消费者成本）
      • 价格传导至终端市场
      • 市占率动态
      • 消费者反应模式
  • 受影响的主要公司
  • 策略产业反应
    • 供应链重组
    • 定价和产品策略
    • 政策参与
  • 展望与未来考虑
• 报销场景
• 技术格局
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 支架
• 插管套件
• 泪点塞
• 管
• 套管和压舌板
• 扩张器
• 其他产品

第六章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 干眼症
• 溢泪症
• 青光眼
• 排水阻塞
• 泪腺发炎
• 其他应用

第七章：市场估计与预测：按材料，2021 - 2034 年

• 主要趋势
• 硅酮
• 不銹钢
• 其他材料

第八章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 眼科诊所
• 诊断中心
• 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• Aurolab
• B. Braun
• Bess Medical
• Braintree
• BVI
• FCI
• GWSG
• Innovia Medical
• JEDMED
• Kaneka Medical Products
• Medennium
• OASIS
• Rumex
• Surtex Instruments
• Walsh Medical Devices

The Global Lacrimal Devices Market was valued at USD 160.2 million in 2024 and is estimated to grow at a CAGR of 4.2% to reach USD 241.5 million by 2034, driven by the increasing prevalence of eye-related health conditions and the continued advancement of healthcare technologies worldwide. As eye care awareness improves and healthcare infrastructure strengthens, particularly in emerging economies, the demand for modern lacrimal solutions is expanding. Rising incidences of dry eye conditions linked to environmental factors, digital screen exposure, and aging demographics are key contributors to this trend. With the focus shifting towards efficient and minimally invasive treatments, the adoption of smart diagnostic tools and innovative surgical methods is rising. Supportive government policies aimed at boosting research and innovation in ophthalmology are also playing a significant role.

Manufacturers prioritize user-centered product design, emphasizing comfort and biocompatibility to align with the growing preference for personalized care. By tailoring lacrimal devices to meet individual patient needs, companies are enhancing treatment outcomes while improving device tolerability and patient adherence. This shift toward personalization also includes developing materials that are less likely to trigger immune responses and can integrate more naturally with ocular tissues. Additionally, the collaborative efforts between healthcare professionals, industry players, and research institutions are fast-tracking the development of more effective lacrimal treatments and devices. These partnerships foster innovation, combining clinical insights with advanced engineering and data-driven design to produce next-generation solutions for conditions like dry eye syndrome and nasolacrimal duct obstruction.

The stents segment is projected to see notable growth with a CAGR of 4.6% and is expected to reach USD 67.9 million by 2034. Their rising use in treating lacrimal system disorders among both elderly and pediatric patients is driving this segment. Enhanced clinical outcomes, simple designs, and user-friendly insertion techniques make stents a preferred choice among eye care specialists. The ongoing refinement of bioresorbable and self-retaining stent designs is helping reduce complications, improving patient experience, and minimizing the need for follow-up procedures.

The dry eye treatments segment held a 40.1% share in 2024 and continues to expand due to growing public and clinical recognition of the condition. The link between dry eye syndrome and chronic conditions has increased the urgency for targeted therapeutic approaches. Advanced technologies in tear management and diagnosis have enhanced accuracy in treatment decisions, prompting wider adoption. Improved awareness of early detection and intervention contributes to the segment's momentum.

United States Lacrimal Devices Market generated USD 53.5 million in 2024 and is set to witness substantial growth ahead, driven by the aging population, which is more prone to lacrimal dysfunctions. As elderly individuals are at a higher risk for chronic illnesses such as arthritis, diabetes, and autoimmune disorders, many of which contribute to tear duct and ocular surface complications, the demand for effective and minimally invasive lacrimal treatments continues to rise. Increased focus on innovative treatment modalities, favorable reimbursement policies, and ongoing improvements in procedural technologies are supporting the market's expansion in the region.

Key players active in this market include Medennium, FCI, B. Braun, Rumex, Bess Medical, Kaneka Medical Products, Surtex Instruments, JEDMED, OASIS, GWSG, Aurolab, Innovia Medical, Braintree, BVI, and Walsh Medical Devices. To solidify their positions, companies invest in R&D to develop biocompatible, efficient, and patient-friendly devices. Strategic collaborations with healthcare institutions help boost product visibility and clinical acceptance. Expanding global distribution networks and seeking regulatory approvals in new regions are common strategies. Firms leverage digital marketing and clinical training programs to enhance practitioner engagement and product utilization.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of eye disease
    • 3.2.1.2 Ease of lacrimal treatment procedures
    • 3.2.1.3 Technological advancements in lacrimal devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High risk of side effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Country-wise response
  • 3.5.2 Impact on the industry
    • 3.5.2.1 Supply-side impact (Cost of manufacturing)
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (Cost to consumers)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Reimbursement scenario
• 3.7 Technology landscape
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Stents
• 5.3 Intubation sets
• 5.4 Punctal plugs
• 5.5 Tubes
• 5.6 Cannula and spatula
• 5.7 Dilator
• 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Dry eye
• 6.3 Epiphora
• 6.4 Glaucoma
• 6.5 Drainage obstruction
• 6.6 Lacrimal gland inflammation
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Silicone
• 7.3 Stainless steel
• 7.4 Other materials

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ophthalmic clinics
• 8.4 Diagnostic centers
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Aurolab
• 10.2 B. Braun
• 10.3 Bess Medical
• 10.4 Braintree
• 10.5 BVI
• 10.6 FCI
• 10.7 GWSG
• 10.8 Innovia Medical
• 10.9 JEDMED
• 10.10 Kaneka Medical Products
• 10.11 Medennium
• 10.12 OASIS
• 10.13 Rumex
• 10.14 Surtex Instruments
• 10.15 Walsh Medical Devices